Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...

Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

Here are the top 5 ovarian cancer articles of 2025; stay up-to-date with all the ovarian cancer content from The American ...

Please provide your email address to receive an email when new articles are posted on . Many premenopausal women do not receive estrogen therapy after treatment for gynecologic cancer despite research ...

There are some things known to increase the risk of gynecologic cancers. Bottom line, being a woman puts you at risk. Each month, I co-moderate a twitter discussion for those impacted by gynecologic ...

Navigating the challenges of cancer treatment and emerging as a survivor is a triumph worth celebrating. Yet, what often ...

Gynecologic oncology has shifted towards surgical de-escalation, emphasizing minimally invasive techniques and sentinel lymph node methods to reduce tissue injury while preserving oncologic outcomes.

SERVICE FOR SOME CANCER PATIENTS WILL END AT MERCY ONE. IT WILL STOP OFFERING SURGERIES FOR CONDITIONS LIKE CANCER OF THE FEMALE REPRODUCTIVE SYSTEM. KCCI PEPPER PURPURA TELLS US WHAT’S NEXT. PEPPER.

Physicians with subspecialties in treating cancer can also be found under listings for Clinical Genetics, Colon & Rectal Surgery, Dermatology, Diagnostic Radiology, Gastroenterology, Obstetrics & ...

Ready. Set. GO…. People are preparing to lace up their running shoes Saturday morning to support the work that’s being done at USA Health Mitchell Cancer Institute for gynecologic cancer research. The ...

MOBILE, Ala. (WALA) - The GO Run for gynecologic oncology will celebrate its 15th year on Saturday, Sept. 17, with an in-person race after being held virtually for the past two years. Presented by the ...